Clinical trial AURA
Avelumab as neoadjuvant therapy in subjects with urothelial muscle invasive bladder cancers
| Cancers | |
|---|---|
| Organ | Ureters - bladder - urethra |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | Institut Jules Bordet |
| EudraCT Identifier | 2017-002758-35 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03674424 |
| Inclusion criteria | Non metastatic urothelial carcinoma candidate for surgeryCisplatin eligible and ineligible |
| Last update |